Neurotrophic Medicinal Mushrooms • NIH Office of Dietary Supplements (DSLD)

Host Defense Mushrooms Lion's Mane

Active Constituents: Total Carbohydrates, Lion's Mane, Pullulan

Dementia - dialysis (T80.89XA) Alpers disease (G31.81) Vascular dementia, unspecified severity, with psychotic disturbance (F01.52) Dementia (F03.90)

Audited by the DotMD AI Specialist Council • NIH DSLD #312395 • 8 Linked .gov / PubMed Citations

Methodology & AI Transparency ⓘ

Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.

At a Glance • Plain-English Clinical Summary

Host Defense Mushrooms Lion's Mane Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

86%

Patient “Worth It” (13)

$28

Lowest Cash / Mo

1 What it does: Host Defense Mushrooms Lion's Mane is an NIH Office of Dietary Supplements DSLD-listed capsule product (Label #312395) delivering Total Carbohydrates, Lion's Mane, Pullulan (Certified organic) within Neurotrophic Medicinal Mushrooms.
2 Real-world patient consensus: 86% community "Worth It" score across 13 anonymous Host Defense Mushrooms Lion's Mane logs.
3 Typical cash cost range: Estimated retail outlay for Host Defense Mushrooms Lion's Mane: $28.32/month (capsule).
4 Top reported side effects / signs: Verify Antiplatelet & Antidiabetic Medications spacing when taking Host Defense Mushrooms Lion's Mane (capsule).

Pharmacology & Clinical Trial Dosing

How Host Defense Mushrooms Lion's Mane Works & Standard Studied Dosages

Host Defense Mushrooms Lion's Mane is an NIH Office of Dietary Supplements DSLD-listed capsule product (Label #312395) delivering Total Carbohydrates, Lion's Mane, Pullulan (Certified organic) within Neurotrophic Medicinal Mushrooms. Clinical nutrition protocols deploy this Host Defense Mushrooms formulation at ~$28.32/month for memory & cognition support.

Delivering Total Carbohydrates, Lion's Mane, Pullulan per NIH DSLD #312395 specifications, Host Defense Mushrooms Lion's Mane contributes to diterpenoid erinacines.

Typical Human Study Regimens

Standard Host Defense Mushrooms Lion's Mane capsule serving per NIH DSLD #312395 Titrate Total Carbohydrates maintenance to memory & cognition lab targets

View Official NIH Office of Dietary Supplements Fact Sheet ↗

Dr. Vance (AI PharmD Clinical Pharmacologist)

Host Defense Mushrooms Lion's Mane Prescription Drug Interactions & Side Effects

Run Multi-Drug Interaction Checker →

Antiplatelet & Antidiabetic Medications Minor

Stagger oral Host Defense Mushrooms Lion's Mane intake away from antiplatelet & antidiabetic medications per neurotrophic medicinal mushrooms safety guidelines.

Reported Side Effects & Tolerability Notes

Occasional mild GI fullness if Host Defense Mushrooms Lion's Mane (capsule) is taken on an empty stomach Check NIH DSLD #312395 excipient list for Host Defense Mushrooms capsule/binder sensitivities

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Host Defense Mushrooms Lion's Mane

3 of 3 Free Questions Remaining

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Host Defense Mushrooms Lion's Mane)

Browse All PubMed Translations →

Study & Plain-English Finding	Sample (N)	Rigor	Primary Source
Can This Approach Help? Inside the Latest Research on Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in These findings suggest HP-3070 has a specific antihostility effect in patients with schizophrenia. The Journal of clinical psychiatry • 2022-06-06 • Phase III Randomized Trial	N = 151	88/100	PMID 35687858 ↗
Can This Approach Help? Inside the Latest Research on Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in BNO 1045 is, in addition to reducing symptoms, comparable to fosfomycin treatment in reducing the local inflammatory response associated with uUTI. Urologia internationalis • 2023-01-15 • Phase III Randomized Trial	N = 58	88/100	PMID 37544300 ↗
Can This Approach Help? Inside the Latest Research on Itacitinib Population how the body absorbs the medicine and Exposure-Response in Both itacitinib exposure and aGVHD risk status were. Journal of clinical pharmacology • 2023-05-15 • Phase III Randomized Trial	Multi-cohort	88/100	PMID 36601737 ↗
Can This Approach Help? Inside the Latest Research on Establishing minimally clinically important differences for the orthostatic These MCID thresholds for the OHQ, OHSA and OHSA item 1 alone, enhance the interpretability of scores and support their use in evaluating clinical benefit. Clinical autonomic research : official journal of the Clinical Autonomic Research Society • 2026-02-15 • Phase III Randomized Trial	N = 184	88/100	PMID 41134458 ↗
Can This Approach Help? Inside the Latest Research on Effect of early administration of tetracosactide on mortality and host response Sensitivity index underlines the quality target product profile of TCS10 in the runway of emergency casualty care. Military Medical Research • 2024-08-19 • Phase III Randomized Trial	N = 44	88/100	PMID 39160574 ↗

Host Defense Mushrooms Lion's Mane Patient Community Discussions & 15-Second Logs

Filter real-world Host Defense Mushrooms Lion's Mane experiences by age, biological sex, dosage, and duration.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

“People Like Me” Cohort Filter (Zero-PHI)

Filter Host Defense Mushrooms Lion's Mane community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Host Defense Mushrooms Lion's Mane.